Digitisation | December 17, 2023
Cipla to further invest Rs. 42 crore in GoApptiv
Expands patient reach to remotest towns by furthering investment in GoApptiv
Expands patient reach to remotest towns by furthering investment in GoApptiv
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Subscribe To Our Newsletter & Stay Updated
